Literature DB >> 24606193

Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study.

Thierry Gustot1, Peter Felleiter, Peter Pickkers, Yasser Sakr, Jordi Rello, Dimitrios Velissaris, Charalampos Pierrakos, Fabio S Taccone, Pavel Sevcik, Christophe Moreno, Jean-Louis Vincent.   

Abstract

BACKGROUND: Infections are a leading cause of death in patients with advanced cirrhosis, but there are relatively few data on the epidemiology of infection in intensive care unit (ICU) patients with cirrhosis. AIMS: We used data from the Extended Prevalence of Infection in Intensive Care (EPIC) II 1-day point-prevalence study to better define the characteristics of infection in these patients.
METHODS: We compared characteristics, including occurrence and types of infections in non-cirrhotic and cirrhotic patients who had not undergone liver transplantation.
RESULTS: The EPIC II database includes 13,796 adult patients from 1265 ICUs: 410 of the patients had cirrhosis. The prevalence of infection was higher in cirrhotic than in non-cirrhotic patients (59 vs. 51%, P < 0.01). The lungs were the most common site of infection in all patients, but abdominal infections were more common in cirrhotic than in non-cirrhotic patients (30 vs. 19%, P < 0.01). Infected cirrhotic patients more often had Gram-positive (56 vs. 47%, P < 0.05) isolates than did infected non-cirrhotic patients. Methicillin-resistant Staphylococcus aureus (MRSA) was more frequent in cirrhotic patients. The hospital mortality rate of cirrhotic patients was 42%, compared to 24% in the non-cirrhotic population (P < 0.001). Severe sepsis and septic shock were associated with higher in-hospital mortality rates in cirrhotic than in non-cirrhotic patients (41% and 71% vs. 30% and 49%, respectively, P < 0.05).
CONCLUSIONS: Infection is more common in cirrhotic than in non-cirrhotic ICU patients and more commonly caused by Gram-positive organisms, including MRSA. Infection in patients with cirrhosis was associated with higher mortality rates than in non-cirrhotic patients.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cirrhosis; infection; mortality; organ failure

Mesh:

Year:  2014        PMID: 24606193     DOI: 10.1111/liv.12520

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  29 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Authors:  Shiv Kumar Sarin; Ashok Choudhury; Manoj K Sharma; Rakhi Maiwall; Mamun Al Mahtab; Salimur Rahman; Sanjiv Saigal; Neeraj Saraf; A S Soin; Harshad Devarbhavi; Dong Joon Kim; R K Dhiman; Ajay Duseja; Sunil Taneja; C E Eapen; Ashish Goel; Q Ning; Tao Chen; Ke Ma; Z Duan; Chen Yu; Sombat Treeprasertsuk; S S Hamid; Amna S Butt; Wasim Jafri; Akash Shukla; Vivek Saraswat; Soek Siam Tan; Ajit Sood; Vandana Midha; Omesh Goyal; Hasmik Ghazinyan; Anil Arora; Jinhua Hu; Manoj Sahu; P N Rao; Guan H Lee; Seng G Lim; Laurentius A Lesmana; Cosmas Rinaldi Lesmana; Samir Shah; V G Mohan Prasad; Diana A Payawal; Zaigham Abbas; A Kadir Dokmeci; Jose D Sollano; Gian Carpio; Ananta Shresta; G K Lau; Md Fazal Karim; Gamal Shiha; Rino Gani; Kemal Fariz Kalista; Man-Fung Yuen; Seema Alam; Rajeev Khanna; Vikrant Sood; Bikrant Bihari Lal; Viniyendra Pamecha; Ankur Jindal; V Rajan; Vinod Arora; Osamu Yokosuka; Madunil A Niriella; Hai Li; Xiaolong Qi; Atsushi Tanaka; Satoshi Mochida; Dominic Ray Chaudhuri; Ed Gane; Khin Maung Win; Wei Ting Chen; Mohd Rela; Dharmesh Kapoor; Amit Rastogi; Pratibha Kale; Archana Rastogi; Chhagan Bihari Sharma; Meenu Bajpai; Virender Singh; Madhumita Premkumar; Sudhir Maharashi; A Olithselvan; Cyriac Abby Philips; Anshu Srivastava; Surender K Yachha; Zeeshan Ahmad Wani; B R Thapa; Anoop Saraya; Ashish Kumar; Manav Wadhawan; Subash Gupta; Kaushal Madan; Puja Sakhuja; Vivek Vij; Barjesh C Sharma; Hitendra Garg; Vishal Garg; Chetan Kalal; Lovkesh Anand; Tanmay Vyas; Rajan P Mathur; Guresh Kumar; Priyanka Jain; Samba Siva Rao Pasupuleti; Yogesh K Chawla; Abhijit Chowdhury; Shahinul Alam; Do Seon Song; Jin Mo Yang; Eileen L Yoon
Journal:  Hepatol Int       Date:  2019-06-06       Impact factor: 6.047

2.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

Review 3.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.

Authors:  Matteo Bassetti; Maddalena Peghin; Alessia Carnelutti; Elda Righi; Maria Merelli; Filippo Ansaldi; Cecilia Trucchi; Cristiano Alicino; Assunta Sartor; Pierluigi Toniutto; Joost Wauters; Wim Laleman; Carlo Tascini; Francesco Menichetti; Roberto Luzzati; Pierluigi Brugnaro; Alessio Mesini; Stefania Raviolo; Francesco G De Rosa; Leonel Lagunes; Jordi Rello; George Dimopoulos; Arnaldo L Colombo; Marcio Nucci; Antonio Vena; Emilio Bouza; Patricia Muñoz; Mario Tumbarello; Raffaella Losito; Ignacio Martin-Loeches; Claudio Viscoli
Journal:  Intensive Care Med       Date:  2017-03-07       Impact factor: 17.440

5.  Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.

Authors:  Philipp Lutz; Felix Goeser; Dominik J Kaczmarek; Stefan Schlabe; Hans Dieter Nischalke; Jacob Nattermann; Achim Hoerauf; Christian P Strassburg; Ulrich Spengler
Journal:  Dig Dis Sci       Date:  2017-06-09       Impact factor: 3.199

6.  Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.

Authors:  Benedikt Simbrunner; Annika Röthenbacher; Helmuth Haslacher; David Bauer; David Chromy; Theresa Bucsics; Philipp Schwabl; Rafael Paternostro; Bernhard Scheiner; Michael Trauner; Mattias Mandorfer; Ilse Schwarzinger; Thomas Reiberger
Journal:  United European Gastroenterol J       Date:  2019-04-05       Impact factor: 4.623

Review 7.  Intensive Care Therapy for Patients with Advanced Liver Diseases.

Authors:  Antonios Katsounas; Ali Canbay
Journal:  Visc Med       Date:  2018-08-08

Review 8.  First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review.

Authors:  Kenya Kamimura; Daisuke Kumaki; Masashi Arita; Yuji Kobayashi; Ken-Ichi Mizuno; Fumiko Kusama; Megumi Kobayashi; Hiroyuki Abe; Yoshifumi Takahashi; Kohei Ogawa; Yoko Shinagawa; Manabu Takeuchi; Yuichi Sato; Hirokazu Kawai; Satoshi Yamagiwa; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2015-09-05

9.  Staphylococcal Toxic Shock Syndrome Caused by an Intravaginal Product. A Case Report.

Authors:  Monica Marton
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

10.  Role of Bacterial Infection in the Development of Acute Liver Failure in Patients with Decompensated Alcoholic Liver Cirrhosis.

Authors:  A S Rodina; M E Shubina; I V Kurbatova; O P Dudanova
Journal:  Bull Exp Biol Med       Date:  2021-07-23       Impact factor: 0.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.